round button
Leave a message

Global Mass Spectrometry Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Mass Spectrometry Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

  • Healthcare
  • Published Report
  • Oct 2024
  • Global
  • 350 Pages
  • No of Tables: 282
  • No of Figures: 43

Global Mass Spectrometry Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 6.34 Billion
Diagram Market Size (Forecast Year)
USD 12.03 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Thermo Fisher Scientific
  • SCIEX
  • Agilent Technologies
  • Waters Corporation
  • PerkinElmer

Global Mass Spectrometry Market Segmentation, By Technology (Hybrid Mass Spectrometry, Single Mass Spectrometry, and Others),  Modality (Benchtop and Standalone),  Application (Life Science Research, Drug Discovery, Environmental TestingFood Testing, Applied Industries, Clinical Diagnostics, and Others),  End User (Pharmaceutical Industry, Research and Academic Institutes, Food & Beverage Industry, Petrochemical Industry, and Others),  Distribution Channel (Direct Tenders, Retail Sales, and Others) – Industry Trends and Forecast to 2031

Mass Spectrometry Market

Mass Spectrometry Market Analysis

The global mass spectrometry market refers to the industry centered around the development, production, and application of mass spectrometry technologies, which are analytical tools used to identify the composition, structure, and quantity of chemical substances based on their mass-to-charge ratio. The market is driven by the rising demand for advanced analytical tools in pharmaceutical and biotech industries for drug development and quality control, and the growing focus on environmental testing and food safety regulations. However, the high cost of mass spectrometry instruments remains a significant restraint, limiting adoption, particularly among smaller laboratories. An opportunity lies in technological advancements like hybrid and portable mass spectrometers, which are expanding the market’s reach into new applications such as clinical diagnostics. A key challenge is the need for skilled professionals to operate and maintain complex systems, which can hinder efficient use and market growth.

Mass Spectrometry MarketMass Spectrometry Market

Mass Spectrometry Market Size

Global mass spectrometry market size was valued at USD 6.34 billion in 2023 and is projected to reach USD 12.03 billion by 2031, with a CAGR of 8.6% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Mass Spectrometry Market Trends

“Rising Adoption in Clinical Diagnostics”

The rising adoption of mass spectrometry in clinical diagnostics is driven by its ability to analyze complex biological samples, advancing personalized medicine and disease diagnostics. In proteomics, it identifies and quantifies proteins linked to diseases like cancer, while in metabolomics, it profiles metabolic changes associated with conditions such as diabetes and neurodegenerative disorders. Mass spectrometry also plays a key role in biomarker discovery, enabling the identification of molecules that signal the presence or progression of diseases, supporting early and accurate diagnosis. This technology enhances personalized treatment by helping tailor therapies to a patient’s unique biological profile and is advancing non-invasive diagnostics through the analysis of fluids like breath, urine, or saliva, improving patient comfort and compliance.

Report Scope and Mass Spectrometry Market Segmentation

Attributes

Mass Spectrometry Key Market Insights

Segments Covered

  • By Technology: Hybrid Mass Spectrometry, Single Mass Spectrometry, and Others
  • By Modality: Benchtop and Standalone
  • By Application: Life Science Research, Drug Discovery, Environmental Testing, Food Testing, Applied Industries, Clinical Diagnostics, and Others
  • By End User: Pharmaceutical Industry, Research and Academic Institutes, Food & Beverage Industry, Petrochemical Industry, and Others
  • By Distribution Channel: Direct Tenders, Retail Sales, and Others

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherland, Switzerland, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea,  Thailand, Indonesia, Malaysia, Singapore, Vietnam, Philippines, Rest of APAC, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, Egypt, U.A.E., Israel, and Rest of MEA

Key Market Players

Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), Agilent Technologies, Inc. (U.S.), Bruker Corp (U.S.) , Waters Corporation(U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Rigaku Corporation (Japan), JEOL Ltd. (U.S.), LECO Corporation(U.S.), Hiden Analytical (UK), Hitachi Ltd. (Japan), Kore Technology (UK), Ametek. Inc. (U.S.)

Market Opportunities

  • Advancements in automation and artificial intelligence (ai) in mass spectrometry
  • Rising adoption of compact and portable mass spectrometers

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Mass Spectrometry Market Definition

Mass spectrometry (often abbreviated as MS) is an analytical technique used to measure the mass-to-charge ratio of ions, allowing for the identification and quantification of compounds within a sample. The process involves ionizing the sample, typically through methods such as electron impact or electrospray ionization, and then accelerating the ions into a mass analyzer. This analyzer separates the ions based on their mass-to-charge ratios, and the resulting data is used to construct a mass spectrum that reveals the composition, structure, and concentration of the molecules present in the sample. Mass spectrometry is widely used in various fields, including chemistry, biochemistry, and environmental science, for applications such as drug analysis, proteomics, and metabolomics.

Mass Spectrometry Market Dynamics

Drivers  

  • Technological Advancements in Mass Spectrometry 

Technological advancements in mass spectrometry have significantly propelled the growth of the global mass spectrometry market by enhancing the precision, speed, and range of applications in various industries. Innovations like the development of hybrid mass spectrometry systems, improved ionization techniques, and the integration of artificial intelligence (AI) and machine learning have broadened the scope of mass spectrometry in fields such as pharmaceuticals, biotechnology, environmental analysis, and food safety. These advancements allow for faster and more accurate detection of molecules, enabling researchers to perform complex analyses with higher sensitivity and reliability. Also, the miniaturization of mass spectrometry devices has facilitated the use of portable systems in point-of-care diagnostics and field testing, expanding their market reach. Continuous improvements in software and data analysis capabilities have also made the technology more accessible, enabling real-time data processing and automation, which reduces human error and enhances throughput in laboratories, further driving demand.

For instance,

  • In June 2023, according to the article published by Bioanalysis zone, innovations like the Orbitrap Astral mass spectrometer have led to greater sensitivity and throughput, particularly benefiting fields like proteomics, diagnostics, and personalized medicine. Also, AI-enhanced data analysis, improved methods for protein interaction studies, and advancements in biomarker quantification. These advancements are driving progress in drug discovery, clinical trials, and disease diagnostics, making mass spectrometry more efficient and scalable. These technological advancements act as a driver in the growth of the market
  • In July 2023, according to the article published in Elsevier, Recent advancements in native Mass Spectrometry (nMS) have improved its ability to analyze biomolecules. Enhanced ionization techniques like electrospray ionization preserve the native state of proteins, while high-resolution mass analyzers, such as Orbitrap and FT-ICR, enable accurate mass measurements of larger biomolecules. Ambient mass spectrometry allows for in situ analysis without extensive sample preparation, expanding applications in clinical diagnostics and environmental studies. The integration of nMS with techniques like chromatography enhances data analysis capabilities, while advanced software facilitates the interpretation of complex data. These developments drive progress in fields like proteomics and drug discovery, enabling detailed analysis of biomolecular structures and interactions
  • In August 2023, according to the article published in Academic Research, the technological advancements of mass spectrometry (MS) in omics technologies, emphasizing its impact on genomics, proteomics, metabolomics, and lipidomics. Key developments include high-resolution mass analyzers, such as Orbitrap and FT-ICR, which enhance sensitivity and accuracy in molecular analysis. Improved ionization techniques, like MALDI and electrospray ionization, facilitate the analysis of diverse biomolecules in their native states. Data-independent acquisition (DIA) allows for comprehensive data collection, improving reproducibility and quantification in complex mixtures. The integration of MS with other omics technologies, along with advancements in microfluidics and automation, streamlines sample preparation and enhances efficiency. Sophisticated software for data analysis aids in interpreting complex datasets, making MS a pivotal tool in omics research and driving innovations in biomarker discovery and personalized medicine.

Advancements in mass spectrometry have significantly boosted its market by improving accuracy, speed, and versatility across multiple industries. Enhanced detection capabilities, portable systems, and smarter data processing have made the technology more accessible and efficient, expanding its use in research, diagnostics, and industrial applications, ultimately driving market growth.              

  • Growing Applications of Mass Spectrometry (MS) In Pharmaceuticals And Biotechnology        

The growing applications of mass spectrometry (MS) in pharmaceuticals and biotechnology are key drivers in the expansion of the global mass spectrometry market. As the pharmaceutical industry increasingly focuses on drug discovery and development, the demand for advanced analytical techniques has surged. MS plays a vital role in various stages of the drug development process, including the analysis of small molecules, biopharmaceuticals, and complex biological matrices, enabling researchers to identify and quantify drugs, metabolites, and impurities with high sensitivity and specificity. Furthermore, advancements in MS technology, such as the integration of high-resolution mass spectrometry and innovative ionization techniques, have facilitated high-throughput screening and metabolomics studies, thereby streamlining workflows and accelerating time-to-market for new therapeutics. Regulatory bodies have also recognized the reliability of mass spectrometry, leading to its acceptance in compliance with stringent safety and efficacy standards. The rise of personalized medicine, which requires detailed biomarker analysis and patient-specific drug profiling, has further amplified the demand for mass spectrometry in the biotech sector. This convergence of technological advancements, regulatory support, and evolving healthcare needs continues to propel the growth of the global mass spectrometry market, positioning it as an indispensable tool for innovation in pharmaceuticals and biotechnology.

For instance,

  • In March 2023, according to the article published in Technology Networks, there is a growing significance of mass spectrometry (MS) in pharmaceutical and biotech applications. Mass spectrometry has an essential role in drug development, quality control, and the analysis of biopharmaceuticals. The technology provides detailed insights into molecular structure and composition, which are crucial for ensuring product efficacy and safety. The demand for more sophisticated analytical methods drives innovation in mass spectrometry, contributing to its expanding use in characterizing biomolecules and bioproducts
  • In September 2023, according to the article published in Elsevier, Quantitative Mass spectrometry allows precise measurement of biomolecules, improving the characterization of proteins, peptides, and metabolites. It optimizes processes like purification and formulation, ensuring higher yields and consistency. Increasing recognition from regulatory agencies further supports its use for method validation. Applications of Mass spectrometry technology, such as high-resolution capabilities and data analysis software, enhance sensitivity and throughput, while integration with other analytical techniques expands its application scope. Overall, quantitative Mass spectrometry is transforming biopharmaceutical development and manufacturing
  • In July 2023, according to the article published in NCBI, Mass spectrometry (MS) is crucial in pharmaceutical analysis, enhancing sensitivity and specificity for detecting low-abundance compounds in complex biological samples. It is utilized across drug development stages and supports applications like metabolomics and proteomics. There is growing significance of mass spectrometry (MS) in pharmaceutical and biotech applications, particularly in drug discovery, development, and quality control. It emphasizes the technology's ability to analyse complex biomolecules, providing accurate and sensitive data essential for modern biopharmaceuticals. Additionally, advancements in MS techniques and instrumentation are accelerating research and enhancing productivity, making it a pivotal tool in ensuring drug safety and efficacy

The rising use of mass spectrometry (MS) in pharmaceuticals and biotechnology is a key factor driving the global mass spectrometry market. Its ability to accurately identify and quantify drugs and metabolites, coupled with advancements in technology for high-throughput screening, has streamlined drug development. Regulatory support and the shift towards personalized medicine further enhance the demand for MS, emphasizing its crucial role in innovation within these sectors.

Mass Spectrometry Market

Opportunities

  • Advancements in Automation and Artificial Intelligence (AI) in Mass Spectrometry

The integration of automation and Artificial Intelligence (AI) in mass spectrometry presents a transformative opportunity for the global market. Advances in automation streamline sample processing and analysis, enhancing throughput and efficiency in laboratories. This allows researchers to handle larger sample volumes and obtain results more quickly, thereby accelerating research timelines. AI-driven data analysis tools can significantly improve the accuracy and speed of interpretation, enabling more complex data sets to be processed with greater precision. Furthermore, machine learning algorithms can optimize experimental conditions, leading to better instrument performance and reduced operational costs. As laboratories increasingly adopt these technologies, the demand for advanced mass spectrometry systems that incorporate automation and AI will grow, driving innovation and market expansion in diverse fields such as pharmaceuticals, environmental testing, and clinical diagnostics.

For instance,

  • In July 2024, according to the article published in Science Direct, the application of AI in interpreting spectroscopic data is rapidly evolving, enabling the extraction of valuable insights from complex datasets. This technological advancement creates a significant opportunity for the global mass spectrometry market by enhancing data analysis capabilities. Improved efficiency and accuracy in results will drive demand for advanced mass spectrometry systems, supporting innovation across various sectors, including pharmaceuticals and environmental testing
  • In June 2024, according to the article published on  the Separation Science, Mass spectrometry presents a unique opportunity for machine learning and AI to enhance data interpretation. Due to the complexity of mass spectra, expert analysis is often required to extract meaningful insights, with many details remaining unclear. However, AI excels in identifying patterns in this data. Tools like Prosit have demonstrated the potential of AI in predicting and detecting peptides, highlighting significant market opportunities

In Feb 2024, according to the article published in NCBI, The integration of machine learning (ML) into mass spectrometry (MS) analysis has gained momentum, with innovative approaches emerging across the field. As deep learning and artificial neural networks (ANNs) are increasingly utilized, it becomes crucial to assess and compare these ML methods. This convergence presents a significant opportunity for the global mass spectrometry market, fostering advancements and enhancing analytical capabilities

In January 2024, according to the article published on Science Direct, Machine learning leverages computational models to extract information directly from data, transforming raw inputs into actionable insights without relying on predefined equations. Applying various AI models to mass spectrometry data yields accurate results in a short timeframe, which is particularly valuable for future in-flight processing of mass spectrometry data. This advancement represents a significant opportunity for the global mass spectrometry market

The rise of automation and artificial intelligence (AI) in mass spectrometry offers significant opportunities for market growth. Automation enhances sample processing and analysis, increasing efficiency and throughput in laboratories. This capability allows for quicker results and the handling of larger sample sizes, thereby speeding up research efforts. AI-powered data analysis improves the accuracy and speed of interpretation, enabling researchers to work with complex datasets more effectively. Additionally, machine learning can optimize experimental conditions, enhancing instrument performance and reducing costs. As more labs adopt these technologies, the demand for advanced mass spectrometry systems that incorporate automation and AI will grow, driving innovation across sectors such as pharmaceuticals, environmental testing, and clinical diagnostics.    

  • Rising Adoption of Compact and Portable Mass Spectrometers

The increasing adoption of compact and portable mass spectrometers presents a significant opportunity for the global mass spectrometry market. These advanced devices facilitate on-site analysis in diverse applications, such as environmental monitoring, food safety testing, and clinical diagnostics. Their small size and user-friendly design make them ideal for use in the field or in remote locations, allowing for immediate results without the need for extensive laboratory infrastructure. As industries seek greater efficiency and rapid data acquisition, the demand for portable mass spectrometry solutions is expected to rise. This trend not only enhances diagnostic capabilities but also promotes innovation in analytical techniques. By catering to the growing need for accessible and efficient testing methods, compact mass spectrometers are poised to play a crucial role in the future of the mass spectrometry market.

For instance,

  • In November 2022, according to the article published in NCBI, Mass spectrometry (MS) is a highly informative analytical method essential for various ‘omics studies. However, traditional mass spectrometers are often bulky and require high vacuum conditions, limiting their accessibility and field use. The development of portable mass spectrometers can greatly broaden the application range and user base for MS analysis, representing a significant opportunity for the global mass spectrometry market
  • In May 2022, according to the article published on Research Gate, the rapid advancement of science and technology has made portable mass spectrometers essential analytical instruments for research. The miniaturization and applications of four types—magnetic sector, time-of-flight, quadrupole, and ion trap mass spectrometers—showcase their compact design and ease of use. This trend highlights a significant opportunity for the global mass spectrometry market

The rising use of compact and portable mass spectrometers creates a valuable opportunity for the global mass spectrometry market. These innovative devices enable on-site analysis across various fields, including environmental monitoring, food safety, and clinical diagnostics. Their small size and ease of use make them perfect for remote locations, providing quick results without needing extensive lab setups. As industries prioritize efficiency and rapid data collection, the demand for these portable solutions is likely to grow. This trend enhances diagnostic capabilities and drives innovation in analytical methods, positioning compact mass spectrometers as vital tools for the future of the mass spectrometry market.  

Restraints/Challenges

  • High Cost of Mass Spectrometry

The high cost of mass spectrometry systems and their associated operational expenses act as a significant restraint in the global mass spectrometry market, limiting accessibility for many laboratories, especially in emerging economies and smaller research institutions. The initial investment required for advanced mass spectrometry instruments is substantial, encompassing not only the purchase price but also expenses related to installation, maintenance, and the need for specialized personnel to operate and interpret the results. Additionally, the ongoing costs of consumables, such as reagents and calibration standards, can further strain budgets, making it challenging for organizations with limited resources to adopt or upgrade their mass spectrometry capabilities. This financial barrier can hinder the adoption of mass spectrometry technologies, particularly in fields that require cost-effective analytical solutions, thereby slowing down advancements in research and clinical applications. Consequently, despite the growing demand for mass spectrometry in various industries, the high cost associated with these technologies continues to pose a significant challenge, potentially limiting market growth and the overall utilization of mass spectrometry in critical applications.

For instance,

In August 2019, according to the article published in American Chemical Society, a triple quadrupole mass spectrometer typically costs around USD 350,000, although this can vary based on its features. A high-resolution time-of-flight instrument generally ranges from USD 350,000 to USD 400,000, while an Orbitrap extended-mass-range model can be priced between approximately USD 400,000 and USD 800,000. The high cost of modern mass spectrometry acts as a restraint in the market growth

In July 2019, according to the article published by Journal of Infectiology & Epidemiology, MALDI-TOF mass spectrometry offers significant advantages in the rapid and accurate identification of microorganisms but its high cost remains a substantial limitation. The expense of acquiring and maintaining mass spectrometry equipment, along with the need for specialized training and infrastructure, poses a barrier to widespread adoption, particularly in resource-limited settings

The prohibitive costs of mass spectrometry systems and their ongoing operational expenses serve as a notable obstacle in the global mass spectrometry market. The substantial initial investment required for advanced instruments, coupled with high maintenance, consumables, and the need for skilled personnel, limits access for many research institutions and smaller labs, particularly in developing regions. This financial burden can deter organizations from adopting or enhancing their mass spectrometry capabilities, ultimately slowing progress in research and clinical applications.          

  • Skilled Workforce Shortage

The mass spectrometry market faces a significant challenge due to the shortage of skilled professionals capable of operating advanced mass spectrometry systems and interpreting complex data. The intricate nature of mass spectrometry demands specialized training and expertise, which can be challenging to find. This shortage not only limits the adoption of mass spectrometry technology, as organizations may hesitate to invest without qualified personnel, but it can also lead to inconsistent results due to variability in data quality and interpretation. Additionally, companies may incur increased training costs to upskill existing staff, further straining operational budgets. The lack of skilled workers can stifle innovation, as new techniques and applications may go unexplored, while limited expertise creates bottlenecks in workflows, slowing down research and analysis processes. Addressing this workforce shortage is crucial for the continued growth and advancement of the mass spectrometry market.

For instance,

  • In February 2023, according to the article published on Biomedical Research Network , the Healthcare is facing a critical shortage of essential medical laboratory professionals who work behind the scenes. This lack of skilled technicians limits the effective operation and analysis capabilities of mass spectrometry systems. As a result, this shortage acts as a significant challenge, hindering the growth and widespread adoption of mass spectrometry in healthcare settings
  • In October 2022, according to the article published by THG PUBLISHING PVT LTD, The Regional Chemical Examiner’s Lab in Kakkanad is experiencing operational challenges due to a shortage of staff and inadequate modern equipment. This situation reflects a broader issue affecting the global mass spectrometry market, where similar constraints can hinder laboratory efficiency and effectiveness. As a result, this staff and equipment deficiency acts as a significant challenge on market growth

The mass spectrometry market is significantly hindered by a shortage of skilled professionals capable of operating advanced systems and analyzing complex data. This lack of expertise restricts technology adoption, as organizations may be reluctant to invest without qualified personnel. Additionally, inconsistent results may arise from varying data interpretations, and companies face increased training costs to develop existing staff. This skills gap can stifle innovation and create workflow bottlenecks, ultimately slowing research and analysis. Addressing the shortage of skilled workers is essential for the continued growth of the mass spectrometry market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Mass Spectrometry Market Scope

The market is segmented on the basis of technology, modality, application, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

  • Hybrid Mass Spectrometry
    • Orbitrap-MS
    •  FT-MS
    •  Others
  •  Single Mass Spectrometry
    • Time of Flight
    •  Quadrupole
    •  Others
  •  Others

Modality

  • Benchtop
  •  Standalone

Application

  • Pharmaceutical Industry
  •  Research and Academic Institutes
  •  Food & Beverage Industry
  •  Petrochemical Industry
  •  Others

Distribution CHannel

  • Direct Tenders
  • Retail Sales
  • Others

Mass Spectrometry Market

Mass Spectrometry Market Regional Analysis

The market is analyzed and market size insights and trends are provided by country, technology, modality, application, end user, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherland, Switzerland, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea,  Thailand, Indonesia, Malaysia, Singapore, Vietnam, Philippines, Rest of APAC, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, Egypt, U.A.E., Israel, Rest of MEA.

North America is expected to dominate the market due to its advanced research infrastructure, significant investments in healthcare and life sciences, and high adoption of cutting-edge technologies like hybrid and tandem mass spectrometry. Strong support from government initiatives and regulatory agencies fosters innovation and drives market growth in the region.

Asia-Pacific is expected to be the fastest growing due to rapid advancements in healthcare infrastructure and increased investments in research and development across the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Mass Spectrometry Market

Mass Spectrometry Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Mass Spectrometry Market Leaders Operating in the Market Are:

  • Thermo Fisher Scientific, Inc. (U.S.)
  • Shimadzu Corporation (Japan)
  • Agilent Technologies, Inc. (U.S.)
  • Bruker Corp (U.S.)
  • Waters Corporation (U.S.)
  • Danaher Corporation (U.S.)
  • PerkinElmer, Inc.
  • Rigaku Corporation
  • JEOL Ltd. (Japan)
  • LECO Corporation
  • Hiden Analytical (England)
  • Hitachi Ltd. (Japan)
  • Kore Technology (UK)
  • Ametek. Inc. (U.S.)

Latest Developments in Mass Spectrometry Market

  • In October 2024, Waters Corporation launched new LC-MS-grade reagents, enzymes, and software to enhance RNA analysis for mRNA vaccines and therapies. The tools simplify sequence confirmation and improve sensitivity, accelerating development while ensuring safety and efficacy for RNA-based pharmaceuticals
  • In June 2024, Agilent Technologies unveiled the 7010D Triple Quadrupole GC/MS System and the ExD Cell for the 6545XT AdvanceBio LC/Q-TOF at ASMS 2024, enhancing sensitivity, structural characterization, and analytical efficiency in food safety, environmental testing, and biopharma research
  • In May 2024, The Bruker Corp completed its acquisition of NanoString Technologies, acquiring key assets including the nCounter, GeoMx, CosMx, and AtoMx™ product lines for approximately USD 392.6 million. This strategic move enhanced Bruker's capabilities in gene expression profiling and spatial transcriptomics for research
  • In October 2023, Waters Corporation has partnered with the University of San Agustin to establish the Philippines' first mass spectrometry imaging center. Equipped with the SYNAPT HDMS, the center aims to advance natural medicine drug discovery for cancer and infectious diseases
  • In June 2023, Agilent Technologies introduced the 6495D LC/TQ and Revident LC/Q-TOF mass spectrometry systems at ASMS 2023, enhancing sensitivity and efficiency for targeted analyses. New MassHunter Explorer and ChemVista software streamline data exploration and identification, revolutionizing workflows in various scientific fields
  • In May 2023, Thermo Fisher and BRIN have partnered to enhance research capabilities in Indonesia, focusing on advancing scientific innovation and collaboration in life sciences, biotechnology, and environmental studies for local researchers


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL MASS SPECTROMETRY MARKET

1.4 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

5 GLOBAL MASS SPECTROMETRY MARKET: REGULATIONS

5.1 REGULATORY AUTHORITIES IN NORTH AMERICA

5.2 REGULATORY AUTHORITIES IN SOUTH AMERICA

5.3 REGULATORY AUTHORITIES IN EUROPE

5.4 REGULATORY AUTHORITIES IN MIDDLE EAST AND AFRICA.

5.5 REGULATORY AUTHORITIES IN ASIA PACIFIC.

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 TECHNOLOGICAL ADVANCEMENTS IN MASS SPECTROMETRY

6.1.2 GROWING APPLICATIONS OF MASS SPECTROMETRY (MS) IN PHARMACEUTICALS AND BIOTECHNOLOGY

6.1.3 DEMAND OF MASS SPECTROMETRY IN ENVIRONMENTAL TESTING AND FOOD SAFETY

6.1.4 ADVANCEMENTS IN PROTEOMICS AND GENOMICS RESEARCH

6.2 RESTRAINTS

6.2.1 HIGH COST OF MASS SPECTROMETRY

6.2.2 COMPETITION FROM ALTERNATIVE TECHNOLOGIES

6.3 OPPORTUNITIES

6.3.1 ADVANCEMENTS IN AUTOMATION AND ARTIFICIAL INTELLIGENCE (AI) IN MASS SPECTROMETRY

6.3.2 GROWING ADOPTION IN CLINICAL LABS

6.3.3 RISING ADOPTION OF COMPACT AND PORTABLE MASS SPECTROMETERS

6.4 CHALLENGES

6.4.1 SKILLED WORKFORCE SHORTAGE

6.4.2 EFFECTIVELY MANAGING AND STORING LARGE VOLUMES OF DATA

7 GLOBAL MASS SPECTROMETRY MARKET, BY TECHNOLOGY

7.1 OVERVIEW

7.2 HYBRID MASS SPECTROMETRY

7.2.1 ORBITRAP-MS

7.2.2 FT-MS

7.2.3 OTHERS

7.3 SINGLE MASS SPECTROMETRY

7.3.1 TIME OF FLIGHT

7.3.2 QUADRUPOLE

7.3.3 OTHERS

7.4 OTHERS

8 GLOBAL MASS SPECTROMETRY MARKET, BY MODALITY

8.1 OVERVIEW

8.2 BENCHTOP

8.3 STANDALONE

9 GLOBAL MASS SPECTROMETRY MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 LIFE SCIENCE RESEARCH

9.3 DRUG DISCOVERY

9.4 ENVIRONMENTAL TESTING

9.5 FOOD TESTING

9.6 APPLIED INDUSTRIES

9.7 CLINICAL DIAGNOSTICS

9.8 OTHERS

10 GLOBAL MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDERS

10.3 RETAIL SALES

10.4 OTHERS

11 GLOBAL MASS SPECTROMETRY MARKET, BY END USER

11.1 OVERVIEW

11.2 PHARMACEUTICAL INDUSTRY

11.3 RESEARCH AND ACADEMIC INSTITUTES

11.4 FOOD & BEVERAGE INDUSTRY

11.5 PETROCHEMICAL INDUSTRY

11.6 OTHERS

12 GLOBAL MASS SPECTROMETRY MARKET, BY REGION

12.1 OVERVIEW

12.2 NORTH AMERICA

12.2.1 U.S

12.2.2 CANADA

12.2.3 MEXICO

12.3 SOUTH AMERICA

12.3.1 BRAZIL

12.3.2 ARGENTINA

12.3.3 REST OF SOUTH AMERICA

12.4 MIDDLE EAST AND AFRICA

12.4.1 SAUDI ARABIA

12.4.2 SOUTH AFRICA

12.4.3 EGYPT

12.4.4 U.A.E

12.4.5 ISRAEL

12.4.6 REST OF MIDDLE EAST AND AFRICA

12.5 EUROPE

12.5.1 GERMANY

12.5.2 FRANCE

12.5.3 U.K.

12.5.4 ITALY

12.5.5 SPAIN

12.5.6 RUSSIA

12.5.7 NETHERLANDS

12.5.8 SWITZERLAND

12.5.9 TURKEY

12.5.10 REST OF EUROPE

12.6 ASIA-PACIFIC

12.6.1 CHINA

12.6.2 JAPAN

12.6.3 INDIA

12.6.4 AUSTRALIA

12.6.5 SOUTH KOREA

12.6.6 THAILAND

12.6.7 INDONESIA

12.6.8 MALAYSIA

12.6.9 SINGAPORE

12.6.10 VIETNAM

12.6.11 PHILIPPINES

12.6.12 REST OF ASIA-PACIFIC

13 GLOBAL MASS SPECTROMETRY MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: GLOBAL

13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

13.3 COMPANY SHARE ANALYSIS: EUROPE

13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14 SWOT ANALYSIS

15 COMPANY PROFILES

15.1 THERMO FISHER SCIENTIFIC INC.

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 SHIMADZU CORPORATION

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 AGILENT TECHNOLOGIES, INC.

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT UPDATES

15.4 BRUKER

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 WATERS CORPORATION

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 AMETEK.INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 DANAHER CORPORATION

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENTS

15.8 HIDEN ANALYTICAL

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENTS

15.9 HITACHI, LTD.B(SUBSIDIARIE COMPANY HITACHI HIGH-TECH INDIA PRIVATE LIMITED)

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.9.4 RECENT DEVELOPMENT

15.1 JEOL LTD.

15.10.1 COMPANY SNAPSHOT

15.10.2 REVENUE ANALYSIS

15.10.3 PRODUCT PORTFOLIO

15.10.4 RECENT DEVELOPMENT

15.11 KORE TECHNOLOGY

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENT

15.12 LECO CORPORATION

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT UPDATES

15.13 PERKINELMER INC

15.13.1 COMPANY SNAPSHOT

15.13.2 REVENUE ANALYSIS

15.13.3 PRODUCT PORTFOLIO

15.13.4 RECENT DEVELOPMENT

15.14 RIGAKU HOLDINGS CORPORATION

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

TABLE 1 GLOBAL MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 2 GLOBAL HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 3 GLOBAL HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 4 GLOBAL SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 5 GLOBAL SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 6 GLOBAL OTHERS IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 7 GLOBAL MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 8 GLOBAL BENCHTOP IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 9 GLOBAL STANDALONE IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 10 GLOBAL MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 11 GLOBAL LIFE SCIENCE RESEARCH IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 12 GLOBAL DRUG DISCOVERY IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 13 GLOBAL ENVIRONMENTAL TESTING IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 14 GLOBAL FOOD TESTING IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 15 GLOBAL APPLIED INDUSTRIES IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 16 GLOBAL CLINICAL DIAGNOSTICS IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 17 GLOBAL OTHERS IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 18 GLOBAL MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 19 GLOBAL DIRECT TENDERS IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 20 GLOBAL RETAIL SALES IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 21 GLOBAL OTHERS IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 22 GLOBAL MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 23 GLOBAL PHARMACEUTICAL INDUSTRY IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 24 GLOBAL RESEARCH AND ACADEMIC INSTITUTES IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 25 GLOBAL FOOD & BEVERAGE INDUSTRY IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 26 GLOBAL PETROCHEMICAL INDUSTRY IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 27 GLOBAL OTHERS IN MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 28 GLOBAL MASS SPECTROMETRY MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 29 NORTH AMERICA MASS SPECTROMETRY MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 30 NORTH AMERICA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 31 NORTH AMERICA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 32 NORTH AMERICA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 33 NORTH AMERICA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 34 NORTH AMERICA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 35 NORTH AMERICA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 36 NORTH AMERICA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 37 U.S. MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 38 U.S. HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 39 U.S. SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 40 U.S. MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 41 U.S. MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 42 U.S. MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 43 U.S. MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 44 CANADA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 45 CANADA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 46 CANADA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 47 CANADA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 48 CANADA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 49 CANADA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 50 CANADA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 51 MEXICO MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 52 MEXICO HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 53 MEXICO SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 54 MEXICO MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 55 MEXICO MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 56 MEXICO MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 57 MEXICO MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 58 SOUTH AMERICA MASS SPECTROMETRY MARKET, BY COUNTRY 2022-2031 (USD THOUSAND)

TABLE 59 SOUTH AMERICA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 60 SOUTH AMERICA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 61 SOUTH AMERICA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 62 SOUTH AMERICA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 63 SOUTH AMERICA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 64 SOUTH AMERICA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 65 SOUTH AMERICA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 66 BRAZIL MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 67 BRAZIL HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 68 BRAZIL SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 69 BRAZIL MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 70 BRAZIL MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 71 BRAZIL MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 72 BRAZIL MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 73 ARGENTINA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 74 ARGENTINA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 75 ARGENTINA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 76 ARGENTINA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 77 ARGENTINA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 78 ARGENTINA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 79 ARGENTINA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 80 REST OF SOUTH AMERICA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 81 MIDDLE EAST AND AFRICA MASS SPECTROMETRY MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 82 MIDDLE EAST AND AFRICA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 83 MIDDLE EAST AND AFRICA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 84 MIDDLE EAST AND AFRICA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 85 MIDDLE EAST AND AFRICA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 86 MIDDLE EAST AND AFRICA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 87 MIDDLE EAST AND AFRICA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 88 MIDDLE EAST AND AFRICA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 89 SAUDI ARABIA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 90 SAUDI ARABIA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 91 SAUDI ARABIA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 92 SAUDI ARABIA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 93 SAUDI ARABIA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 94 SAUDI ARABIA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 95 SAUDI ARABIA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 96 SOUTH AFRICA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 97 SOUTH AFRICA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 98 SOUTH AFRICA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 99 SOUTH AFRICA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 100 SOUTH AFRICA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 101 SOUTH AFRICA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 102 SOUTH AFRICA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 103 EGYPT MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 104 EGYPT HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 105 EGYPT SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 106 EGYPT MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 107 EGYPT MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 108 EGYPT MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 109 EGYPT MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 110 U.A.E. MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 111 U.A.E. HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 112 U.A.E. SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 113 U.A.E. MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 114 U.A.E. MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 115 U.A.E. MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 116 U.A.E. MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 117 ISRAEL MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 118 ISRAEL HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 119 ISRAEL SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 120 ISRAEL MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 121 ISRAEL MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 122 ISRAEL MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 123 ISRAEL MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 124 REST OF MIDDLE EAST AND AFRICA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 125 EUROPE MASS SPECTROMETRY MARKET, BY COUNTRY 2022-2031 (USD THOUSAND)

TABLE 126 EUROPE MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 127 EUROPE HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 128 EUROPE SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 129 EUROPE MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 130 EUROPE MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 131 EUROPE MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 132 EUROPE MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 133 GERMANY MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 134 GERMANY HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 135 GERMANY SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 136 GERMANY MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 137 GERMANY MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 138 GERMANY MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 139 GERMANY MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 140 FRANCE MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 141 FRANCE HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 142 FRANCE SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 143 FRANCE MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 144 FRANCE MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 145 FRANCE MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 146 FRANCE MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 147 U.K. MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 148 U.K. HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 149 U.K. SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 150 U.K. MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 151 U.K. MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 152 U.K. MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 153 U.K. MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 154 ITALY MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 155 ITALY HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 156 ITALY SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 157 ITALY MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 158 ITALY MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 159 ITALY MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 160 ITALY MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 161 SPAIN MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 162 SPAIN HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 163 SPAIN SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 164 SPAIN MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 165 SPAIN MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 166 SPAIN MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 167 SPAIN MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 168 RUSSIA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 169 RUSSIA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 170 RUSSIA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 171 RUSSIA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 172 RUSSIA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 173 RUSSIA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 174 RUSSIA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 175 NETHERLANDS MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 176 NETHERLANDS HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 177 NETHERLANDS SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 178 NETHERLANDS MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 179 NETHERLANDS MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 180 NETHERLANDS MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 181 NETHERLANDS MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 182 SWITZERLAND MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 183 SWITZERLAND HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 184 SWITZERLAND SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 185 SWITZERLAND MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 186 SWITZERLAND MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 187 SWITZERLAND MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 188 SWITZERLAND MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 189 TURKEY MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 190 TURKEY HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 191 TURKEY SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 192 TURKEY MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 193 TURKEY MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 194 TURKEY MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 195 TURKEY MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 196 REST OF EUROPE MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 197 ASIA-PACIFIC MASS SPECTROMETRY MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 198 ASIA-PACIFIC MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 199 ASIA-PACIFIC HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 200 ASIA-PACIFIC SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 201 ASIA-PACIFIC MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 202 ASIA-PACIFIC MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 203 ASIA-PACIFIC MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 204 ASIA-PACIFIC MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 205 CHINA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 206 CHINA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 207 CHINA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 208 CHINA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 209 CHINA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 210 CHINA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 211 CHINA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 212 JAPAN MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 213 JAPAN HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 214 JAPAN SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 215 JAPAN MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 216 JAPAN MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 217 JAPAN MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 218 JAPAN MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 219 INDIA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 220 INDIA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 221 INDIA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 222 INDIA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 223 INDIA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 224 INDIA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 225 INDIA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 226 AUSTRALIA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 227 AUSTRALIA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 228 AUSTRALIA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 229 AUSTRALIA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 230 AUSTRALIA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 231 AUSTRALIA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 232 AUSTRALIA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 233 SOUTH KOREA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 234 SOUTH KOREA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 235 SOUTH KOREA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 236 SOUTH KOREA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 237 SOUTH KOREA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 238 SOUTH KOREA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 239 SOUTH KOREA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 240 THAILAND MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 241 THAILAND HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 242 THAILAND SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 243 THAILAND MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 244 THAILAND MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 245 THAILAND MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 246 THAILAND MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 247 INDONESIA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 248 INDONESIA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 249 INDONESIA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 250 INDONESIA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 251 INDONESIA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 252 INDONESIA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 253 INDONESIA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 254 MALAYSIA MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 255 MALAYSIA HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 256 MALAYSIA SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 257 MALAYSIA MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 258 MALAYSIA MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 259 MALAYSIA MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 260 MALAYSIA MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 261 SINGAPORE MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 262 SINGAPORE HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 263 SINGAPORE SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 264 SINGAPORE MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 265 SINGAPORE MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 266 SINGAPORE MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 267 SINGAPORE MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 268 VIETNAM MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 269 VIETNAM HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 270 VIETNAM SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 271 VIETNAM MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 272 VIETNAM MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 273 VIETNAM MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 274 VIETNAM MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 275 PHILIPPINES MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

TABLE 276 PHILIPPINES HYBRID MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 277 PHILIPPINES SINGLE MASS SPECTROMETRY IN MASS SPECTROMETRY MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 278 PHILIPPINES MASS SPECTROMETRY MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 279 PHILIPPINES MASS SPECTROMETRY MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 280 PHILIPPINES MASS SPECTROMETRY MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 281 PHILIPPINES MASS SPECTROMETRY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 282 REST OF ASIA-PACIFIC MASS SPECTROMETRY MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)

List of Figure

FIGURE 1 GLOBAL MASS SPECTROMETRY MARKET: SEGMENTATION

FIGURE 2 GLOBAL MASS SPECTROMETRY MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL MASS SPECTROMETRY MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL MASS SPECTROMETRY MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL MASS SPECTROMETRY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL MASS SPECTROMETRY MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL MASS SPECTROMETRY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL MASS SPECTROMETRY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL MASS SPECTROMETRY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL MASS SPECTROMETRY MARKET: MARKET END USER COVERAGE GRID

FIGURE 11 GLOBAL MASS SPECTROMETRY MARKET: SEGMENTATION

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL MASS SPECTROMETRY MARKET AND ASIA PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031

FIGURE 15 GLOBAL MASS SPECTROMETRY MARKET

FIGURE 16 HYBRID MASS SPECTROMETRY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MASS SPECTROMETRY MARKET IN 2024 & 2031

FIGURE 17 ASIA PACIFIC IS THE FASTEST GROWING MARKET FOR THE GLOBAL MASS SPECTROMETRY MARKET IN 2024 & 2031

FIGURE 18 DROC ANALYSIS

FIGURE 19 GLOBAL MASS SPECTROMETRY MARKET: BY TECHNOLOGY, 2023

FIGURE 20 GLOBAL MASS SPECTROMETRY MARKET: BY TECHNOLOGY, 2024-2031 (USD THOUSAND)

FIGURE 21 GLOBAL MASS SPECTROMETRY MARKET: BY TECHNOLOGY, CAGR (2024-2031)

FIGURE 22 GLOBAL MASS SPECTROMETRY MARKET: BY TECHNOLOGY, LIFELINE CURVE

FIGURE 23 GLOBAL MASS SPECTROMETRY MARKET: BY MODALITY, 2023

FIGURE 24 GLOBAL MASS SPECTROMETRY MARKET: BY MODALITY, 2024-2031 (USD THOUSAND)

FIGURE 25 GLOBAL MASS SPECTROMETRY MARKET: BY MODALITY, CAGR (2024-2031)

FIGURE 26 GLOBAL MASS SPECTROMETRY MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 27 GLOBAL MASS SPECTROMETRY MARKET: BY APPLICATION, 2023

FIGURE 28 GLOBAL MASS SPECTROMETRY MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)

FIGURE 29 GLOBAL MASS SPECTROMETRY MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 30 GLOBAL MASS SPECTROMETRY MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 31 GLOBAL MASS SPECTROMETRY MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 32 GLOBAL MASS SPECTROMETRY MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)

FIGURE 33 GLOBAL MASS SPECTROMETRY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 34 GLOBAL MASS SPECTROMETRY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 35 GLOBAL MASS SPECTROMETRY MARKET: BY END USER, 2023

FIGURE 36 GLOBAL MASS SPECTROMETRY MARKET: BY END USER, 2024-2031 (USD THOUSAND)

FIGURE 37 GLOBAL MASS SPECTROMETRY MARKET: BY END USER, CAGR (2024-2031)

FIGURE 38 GLOBAL MASS SPECTROMETRY MARKET: BY END USER, LIFELINE CURVE

FIGURE 39 GLOBAL MASS SPECTROMETRY MARKET: SNAPSHOT (2023)

FIGURE 40 GLOBAL MASS SPECTROMETRY MARKET: COMPANY SHARE 2022 (%)

FIGURE 41 NORTH AMERICA MASS SPECTROMETRY MARKET: COMPANY SHARE 2023 (%)

FIGURE 42 EUROPE MASS SPECTROMETRY MARKET: COMPANY SHARE 2023 (%)

FIGURE 43 ASIA-PACIFIC MASS SPECTROMETRY MARKET: COMPANY SHARE 2023 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Segmentation, By Technology (Hybrid Mass Spectrometry, Single Mass Spectrometry, and Others),  Modality (Benchtop and Standalone),  Application (Life Science Research, Drug Discovery, Environmental Testing, Food Testing, Applied Industries, Clinical Diagnostics, and Others),  End User (Pharmaceutical Industry, Research and Academic Institutes, Food & Beverage Industry, Petrochemical Industry, and Others),  Distribution Channel (Direct Tenders, Retail Sales, and Others) – Industry Trends and Forecast to 2031 .
The Global Mass Spectrometry Market size was valued at USD 6.34 USD Billion in 2023.
The Global Mass Spectrometry Market is projected to grow at a CAGR of 8.6% during the forecast period of 2024 to 2031.
The major players operating in the market include Thermo Fisher Scientific , SCIEX, Agilent Technologies , Waters Corporation, PerkinElmer , Shimadzu Corporation, Bruker, Analytik Jena GmbH+Co. KG, JEOL , Rigaku Corporation, LECO Corporation, Hiden Analytical, Hitachi , KORE TECHNOLOGY, Eurofins Scientific, Ion Science, AMETEK. , Danaher-.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherland, Switzerland, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea,  Thailand, Indonesia, Malaysia, Singapore, Vietnam, Philippines, Rest of APAC, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, Egypt, U.A.E., Israel, and Rest of MEA.
Testimonial
a